EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pancreatic cancer: The RAS paradigm shift

Samuel P Soff iD, Eileen M O'Reilly iD

PLOS Medicine · 29.10.2026 · 23 (10) · e1005283

DOI: 10.1371/journal.pmed.1005283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 29.10.2026. Verfasst von Samuel P Soff und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medicine, New York, New York, United States of America. Hauptthemen laut MEDLINE: Adenocarcinoma, Antineoplastic Agents, Pancreatic Neoplasms, ras Proteins. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment approaches for pancreatic adenocarcinoma, an aggressive disease with poor prognosis, are evolving beyond cytotoxic chemotherapy. Recent advances in RAS targeting with small molecules are redefining therapeutic paradigms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaAntineoplastic AgentsPancreatic Neoplasmsras ProteinsHumans

Substanzen

Antineoplastic Agentsras Proteins

Autor:innen und Institutionen

  • Department of Medicine, Weill Cornell Medicine, New York, New York, United States of America.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.

ORCID-Profile: Samuel P Soff, Eileen M O'Reilly

Zitieren

APA

Soff, S. P., & O'Reilly, E. M. (2026). Pancreatic cancer: The RAS paradigm shift. PLOS Medicine, 23(10), e1005283. https://doi.org/10.1371/journal.pmed.1005283

Vancouver

Soff SP, O'Reilly EM. Pancreatic cancer: The RAS paradigm shift. PLOS Medicine. 2026;23(10):e1005283. doi:10.1371/journal.pmed.1005283

BibTeX
@article{Soff2026,
  author = {Soff, Samuel P and O'Reilly, Eileen M},
  title = {Pancreatic cancer: The RAS paradigm shift},
  journal = {PLOS Medicine},
  year = {2026},
  volume = {23},
  number = {10},
  pages = {e1005283},
  doi = {10.1371/journal.pmed.1005283}
}
Kostenlos starten →